Repare Therapeutics Inc.

RPTX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$3-$17-$30-$29
Dep. & Amort.$0$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$4$5
Change in WC$1-$0-$4-$4
Other Non-Cash-$2-$2$0-$0
Operating Cash Flow$3-$16-$29-$27
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$1$0$0
Inv. Purchases-$8-$39-$8-$19
Inv. Sales/Matur.$10$37$37$51
Other Inv. Act.$0$0$0$0
Investing Cash Flow$3-$1$29$32
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect-$0$0$0-$0
Net Chg. in Cash$5-$17-$0$4
Supplemental Information
Beg. Cash$68$84$85$81
End Cash$73$68$84$85
Free Cash Flow$3-$16-$29-$27
Repare Therapeutics Inc. (RPTX) Financial Statements & Key Stats | AlphaPilot